These ASX shares could rise 25% to 30%

Big returns could be on offer with these shares according to analysts.

| More on:
a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The share market has historically delivered investors a return of 10% per annum.

While this is a very good return, there are some ASX shares that have been tipped to rise significantly more than this over the next 12 months.

Let's take a look at three ASX shares that analysts believe have market-beating potential:

Amotiv Ltd (ASX: AOV)

The first ASX share that could have plenty of upside is Amotiv. Until recently, it was known as GUD Holdings. It is a diversified automotive parts company and the name behind brands such as Narva and Ryco.

Morgans is a fan of the company and has an add rating and $13.71 price target on its shares. This implies potential upside of 30% for investors. It commented:

GUD is a high-quality business with an entrenched market position in its core operations and deep growth opportunities in new markets. We view GUD's investment case as compelling, a robust earnings base of predominantly non-discretionary products, structural industry tailwinds supporting organic growth and ongoing accretive M&A optionality. We view the ~12x multiple as undemanding given the resilient earnings and long-duration growth outlook for the business ahead.

Endeavour Group Ltd (ASX: EDV)

Over at Goldman Sachs, its analysts believe this drinks giant's shares are cheap. Last week, the broker reaffirmed its buy rating with an improved price target of $6.50. Based on where the ASX share is currently trading, this suggests that upside of 28% is possible for investors.

The broker likes Endeavour due to its defensive qualities and attractive valuation. It commented:

Our Buy thesis on the stock is based on the following key drivers: 1) Market share gain (already 40% market share) in defensive alcohol retail from consumer data and loyalty advantages; 2) Organic reopening beneficiary with its hotels/pubs business back to pre-COVID sales/property. We believe EDV is trading at a relatively attractive valuation, with potential downside from EGM tax changes already fully priced in.

Lynas Rare Earths Ltd (ASX: LYC)

Bell Potter thinks that this rare earths producer's shares are undervalued at current levels. Last week, the broker put a buy rating and $7.80 price target on its shares. This implies potential upside of 31% for investors over the next 12 months.

Its analysts believe that rare earths prices are close to rebounding from recent weakness. It said:

We continue to see prices painstakingly grind higher from current levels through to the end of the year. China domestic supply may continue to keep a lid on rapid price revisions, however not at current levels. Reports of activity over March highlighted a reduction in NdPr oxide imports into China and a reluctance of domestic miners to sell material to downstream magnet makers whose stockpiles were bottoming out. Combine this with a rapid rise in EV production globally and you have a more positive outlook for NdPr.

Motley Fool contributor James Mickleboro has positions in Endeavour Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man in a business suit peers through binoculars as two businesswomen stand beside him looking straight ahead at the camera.
Broker Notes

What this expert predicts will be the best-performing ASX sectors in FY25

These sectors could be the ones to watch, according to one expert.

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Broker Notes

Buy this ASX 200 stock for 20% upside and a 6% dividend yield

Looking for big returns? Bell Potter thinks this is the stock to buy.

Read more »

Two male professional analysts discuss share price movements shown on the computer screen in front of them, with one pointing to a screen
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Four people gather around laptop and cheer
Broker Notes

3 of the best ASX 200 stocks to buy in FY25

Big returns and buy ratings. That's what Bell Potter is saying about these shares.

Read more »

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

'Obvious buying opportunity': Top broker says beaten-up ASX All Ords stock has 253% upside

Wilsons analysts say the market has misread top-line medical trial results released this week.

Read more »

Senior woman using cpap machine to stop choking and snoring from obstructive sleep apnoea with bokeh and morning light background.
Broker Notes

Should you pounce on ResMed shares at around $28?

Here's what top broker Citi says.

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »